Literature DB >> 492235

Factor X deficiency in primary amyloidosis: resolution after splenectomy.

P R Greipp, R A Kyle, E J Bowie.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 492235     DOI： 10.1056/NEJM197911083011907

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Diagnosis and treatment of amyloidosis.

Authors:  P N Hawkins
Journal:  Ann Rheum Dis       Date:  1997-11       Impact factor: 19.103

Review 2.  Hemostatic changes in patients with malignancy.

Authors:  G H Goldsmith
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

3.  Reversible functional asplenia and subcapsular liver hematoma--two distinctive manifestations of amyloidosis.

Authors:  E Levy-Lahad; D Steiner-Salz; N Berkman; R Chisin; P Levensart; E Leitersdorf
Journal:  Klin Wochenschr       Date:  1987-11-16

Review 4.  Amyloidosis associated bleeding diatheses in the surgical patient.

Authors:  A R Mizutani; C F Ward
Journal:  Can J Anaesth       Date:  1990-11       Impact factor: 5.063

5.  Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients.

Authors:  Carrie A Thompson; Robert Kyle; Morie Gertz; John Heit; Rajiv Pruthi; Animesh Pardanani
Journal:  Am J Hematol       Date:  2010-03       Impact factor: 10.047

Review 6.  Successful perioperative management of factor X deficiency associated with primary amyloidosis.

Authors:  Kazuaki Takabe; Peter R Holman; Kenneth D Herbst; Catherine A Glass; Michael Bouvet
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

Review 7.  Disorders of platelet function: mechanisms, diagnosis and management.

Authors:  L B Huebsch; L A Harker
Journal:  West J Med       Date:  1981-02

8.  Gastrointestinal Amyloidosis: Approach to Treatment.

Authors:  Peter D. Poullos; Neil Stollman
Journal:  Curr Treat Options Gastroenterol       Date:  2003-02

9.  Factor X deficiency: an uncommon presentation of AL amyloidosis.

Authors:  Ajaydas T Manikkan
Journal:  Ups J Med Sci       Date:  2012-06-01       Impact factor: 2.384

10.  Successful treatment of a noninhibitory antibody-mediated acquired factor X deficiency in a patient with marginal-zone lymphoma.

Authors:  Annemarie Meenhuis; Rianne van Vliet; Francisca Hudig; Paula F Ypma; Martin R Schipperus; Martine J Hollestelle
Journal:  Clin Case Rep       Date:  2015-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.